In Sight: My Life in Science and Biotech. Cet article n’est pas disponible.
Langue : anglais
Edité par - -, 2020
- Livre relié
- Occasion

Vendeur : Bahamut Media, Reading, Royaume-UniBahamut Media
Vendeur AbeBooks depuis 15 août 2012
Etat: Occasion - Assez bon
EUR 29,95
A propos de cet article
This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping.
N° de réf. du vendeur 6545-9781487508319
- Titre
- In Sight: My Life in Science and Biotech
- Auteur
- -
- Éditeur
- - -
- Année de publication
- 2020
- État de l'article
- Very Good
- Reliure
- hardcover
- Langue
- anglais
- ISBN à 10 chiffres
- 148750831X
- ISBN à 13 chiffres
- 9781487508319
In Sight is a memoir about how a love of science and discovery drove Julia Levy, a celebrated scholar and biotech CEO, to work her way through gender bias in order to achieve academic and professional recognition. Her story traces the unconventional invention of a breakthrough drug treatment from its development from laboratory research to its application as a medical treatment for vision loss.
Told from a female perspective, In Sight is a unique and personal story covering Levy's early years as a refugee, her university training in the UK, and her appointment as professor at the University of British Columbia. Years spent as an academic led the author to unexpected exposure to the biotechnology industry and a chance meeting with colleagues that led to the formation of a lucrative biotechnology company, known today as QLT Inc. The bulk of the book covers the years spent building the company, and Levy's surprising transition from chief scientific officer to CEO. In Sight is an honest description of the trials of drug development, the tensions inherent in the commercialization of health innovations, and the truly remarkable hurdles faced by women in the scientific community.
« Synopsis » peut appartenir à une autre édition de cet ouvrage.
À propos de l’auteur
« A propos de ce titre » peut appartenir à une autre édition de cet ouvrage.